InvestorsHub Logo
Followers 4
Posts 563
Boards Moderated 0
Alias Born 02/15/2023

Re: dennisdave post# 596427

Saturday, 05/27/2023 10:23:32 AM

Saturday, May 27, 2023 10:23:32 AM

Post# of 707756
Covid excuses in 2023? Can they just admit that they can't operate on any normal kind of schedule. Submission taking over 1 year from TLD is unheard of if you follow other biotechs.

Post-COVID difficulties continue to impact the Company’s programs and operations, due to backlogs in the supply chain, at clinical trial sites, and at regulators.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News